Summit reports HARMONi survival hazard ratio of 0.76
Summit Therapeutics (NASDAQ:SMMT) reported a 0.76 overall-survival hazard ratio in its updated global Phase III HARMONi analysis submitted to the FDA.

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Summit Therapeutics (NASDAQ:SMMT) reported a 0.76 overall-survival hazard ratio in its updated global Phase III HARMONi analysis submitted to the FDA.
AT&T (NYSE:T) reported second-quarter revenue of $31.6 billion, up 2.3%, as fiber and wireless customer growth supported higher earnings.
Joby Aviation (NYSE:JOBY) signed a multi-year agreement making Virgin Atlantic its exclusive UK airline partner for air taxi services.
Ripple Prime has been shortlisted in four categories at the 2026 Hedgeweek US Awards as Ripple continues expanding its presence in institutional financial markets.
Regulators commenced Federal Court proceedings against Dusk (ASX:DSK) over alleged safety breaches involving 29 button battery product lines.
Atturra (ASX:ATA) expects full-year underlying earnings to meet guidance despite reporting lower top-line revenue.
Financial regulators are increasing scrutiny of crypto perpetual futures after warning that retail investors face significant risks from highly leveraged trading.
Origin Energy (ASX:ORG) is investigating a potential security incident that may involve unauthorised access to customer data.
MONEYME (ASX:MME) grew its total loan book past $1.23 billion in annual loan originations.
Brazilian Rare Earths (ASX:BRE) secured $50 million through the maximum subscription initial public offering of spin-off entity Alurion Resources.